NCT02049112View on ClinicalTrials.gov

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

June 30, 2013

Conditions
XerostomiaHyposalivationHead and Neck CancerSjögren Syndrome
Interventions
DEVICE

Salivary equivalent

14-day treatment with salivary equivalent sticks

DEVICE

Aequasyal

14-day treatment with Aequasyal oral spray

DEVICE

Biotene

14-day treatment with Biotene oral spray

Trial Locations (1)

78200

Leopold Bellan Private Hospital, Magnanville

All Listed Sponsors
lead

Unither Pharmaceuticals, France

INDUSTRY

NCT02049112 - A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study | Biotech Hunter | Biotech Hunter